{"id":231798,"date":"2026-09-04T17:27:56","date_gmt":"2026-09-04T11:57:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=231798"},"modified":"2026-09-04T17:27:58","modified_gmt":"2026-09-04T11:57:58","slug":"is-zydus-wellness-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Zydus Wellness a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Zydus Wellness share price around Rs 534. 12.7% below 52-week high of Rs 612. Q1 FY27 revenue Rs 1,441 crore, up 66.8% YoY. PAT Rs 119 crore, down 7.0%. PE 91x.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Zydus Wellness&#8217; Q1 FY27 results were mixed, with revenue at Rs 1,441 crore but PAT falling 7% to Rs 119 crore. The Zydus Wellness share price near Rs 534 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Zydus Wellness is a good buy right now.<\/p>\n<\/div>\n<p>The Zydus Wellness share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Zydus Wellness is a health, wellness and nutrition FMCG company under the Zydus Group, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n<p>Revenue for the quarter came in at Rs 1,441 crore, up 66.8% year on year, while profit after tax came in at Rs 119 crore, down 7.0% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Zydus Wellness share price from here.<\/p>\n<p>This piece works through the quarter&#8217;s financial highlights, the business factors behind the numbers, where the Zydus Wellness share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=zydus-wellness_q1fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Zydus_Wellness_Q1_FY27_Financial_Highlights\" title=\"Zydus Wellness Q1 FY27 Financial Highlights\">Zydus Wellness Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Zydus_Wellness_Q1_FY27_Performance_Analysis\" title=\"Zydus Wellness Q1 FY27 Performance Analysis\">Zydus Wellness Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Key_Business_Factors_in_Q1_FY27\" title=\"Key Business Factors in Q1 FY27\">Key Business Factors in Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Revenue_Trend\" title=\"Revenue Trend\">Revenue Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Margin_Movement\" title=\"Margin Movement\">Margin Movement<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Balance_Sheet_Position\" title=\"Balance Sheet Position\">Balance Sheet Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Valuation_Context\" title=\"Valuation Context\">Valuation Context<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Zydus_Wellness_Share_Price_Outlook_for_FY27\" title=\"Zydus Wellness Share Price Outlook for FY27\">Zydus Wellness Share Price Outlook for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Zydus_Wellness_Stock_Performance\" title=\"Zydus Wellness Stock Performance\">Zydus Wellness Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Valuation_Risk\" title=\"Valuation Risk\">Valuation Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Profitability_Risk\" title=\"Profitability Risk\">Profitability Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Leverage_Risk\" title=\"Leverage Risk\">Leverage Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Sector_and_Demand_Risk\" title=\"Sector and Demand Risk\">Sector and Demand Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Frequently_Asked_Questions_on_Zydus_Wellness_Q1_FY27_Results\" title=\"Frequently Asked Questions on Zydus Wellness Q1 FY27 Results\">Frequently Asked Questions on Zydus Wellness Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#What_were_Zydus_Wellness_Q1_FY27_results\" title=\"What were Zydus Wellness&#8217; Q1 FY27 results?\">What were Zydus Wellness&#8217; Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Is_Zydus_Wellness_a_good_buy_after_its_Q1_FY27_results\" title=\"Is Zydus Wellness a good buy after its Q1 FY27 results?\">Is Zydus Wellness a good buy after its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#What_is_the_Zydus_Wellness_share_price_today\" title=\"What is the Zydus Wellness share price today?\">What is the Zydus Wellness share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#What_is_Zydus_Wellness_revenue_and_profit_for_Q1_FY27\" title=\"What is Zydus Wellness&#8217; revenue and profit for Q1 FY27?\">What is Zydus Wellness&#8217; revenue and profit for Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#Did_Zydus_Wellness_declare_a_dividend_with_its_Q1_FY27_results\" title=\"Did Zydus Wellness declare a dividend with its Q1 FY27 results?\">Did Zydus Wellness declare a dividend with its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#What_is_Zydus_Wellness_PE_ratio_and_is_it_expensive\" title=\"What is Zydus Wellness&#8217; PE ratio and is it expensive?\">What is Zydus Wellness&#8217; PE ratio and is it expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#What_are_the_key_risks_for_Zydus_Wellness_investors_right_now\" title=\"What are the key risks for Zydus Wellness investors right now?\">What are the key risks for Zydus Wellness investors right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/is-zydus-wellness-a-good-buy-after-q1-fy27-results\/#What_is_Zydus_Wellness_promoter_shareholding\" title=\"What is Zydus Wellness&#8217; promoter shareholding?\">What is Zydus Wellness&#8217; promoter shareholding?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Wellness_Q1_FY27_Financial_Highlights\"><\/span><strong>Zydus Wellness Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\">\n<thead>\n<tr style=\"background: #F0F0F0;\">\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Metric<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY27<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY26<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Revenue<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 1,441 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 864 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">66.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">EBITDA<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 246 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 159 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">54.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Operating Margin<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">17.2%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">18.5%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">NA<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Profit Before Tax<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 162 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 145 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">11.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Net Profit \/ (Loss)<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 119 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 128 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">-7.0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Wellness_Q1_FY27_Performance_Analysis\"><\/span><strong>Zydus Wellness Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Zydus Wellness Fundamentals on Univest Screener<\/strong><\/a><\/p>\n<p>Revenue growth of 66.8% for the quarter came from steady demand across the company&#8217;s core business, keeping the topline trend intact for the health and wellness FMCG sector.<\/p>\n<p>Profitability is where the quarter disappointed. PAT fell 7% year on year to Rs 119 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Zydus Wellness share price this quarter.<\/p>\n<p>On a sequential basis, revenue moved down 3.0% sequentially from Rs 1,486 crore in the March 2026 quarter and net profit moved down 26.6% sequentially from Rs 162 crore in the prior quarter, giving a fuller picture of the trend behind the Zydus Wellness share price than the year on year comparison alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q1_FY27\"><\/span><strong>Key Business Factors in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Trend\"><\/span><strong>Revenue Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Zydus Wellness&#8217; revenue grew 66.8% year on year this quarter, taking the quarterly base to Rs 1,441 crore in a health and wellness FMCG business that remains sensitive to demand and pricing cycles that ultimately feed through to the Zydus Wellness share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Movement\"><\/span><strong>Margin Movement<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>EBITDA rose 54.8% to Rs 246 crore, and operating margin moved to 17.2% from 18.5% a year earlier, a sign that cost control or pricing held up during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Position\"><\/span><strong>Balance Sheet Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Zydus Wellness&#8217; debt-to-equity ratio stands at 0.55, a level worth monitoring given the quarter&#8217;s margin trend.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Context\"><\/span><strong>Valuation Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at a PE of 91.0x against an industry average of 35.7x, a premium that this quarter&#8217;s results will need to justify going forward.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No interim dividend was declared alongside Zydus Wellness&#8217; Q1 FY27 results. The stock currently carries a trailing dividend yield of 0.22%, based on dividends paid over the last year. Investors tracking the Zydus Wellness share price for income should watch the company&#8217;s announcements around its next annual results for any dividend decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Wellness_Share_Price_Outlook_for_FY27\"><\/span><strong>Zydus Wellness Share Price Outlook for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The key question for the rest of FY27 is whether Zydus Wellness can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Zydus Wellness share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.<\/p>\n<p>A stabilising or improving margin trend in the next result would be the clearest signal that this quarter&#8217;s profit decline was a temporary setback rather than the start of a longer slide for the Zydus Wellness share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Wellness_Stock_Performance\"><\/span><strong>Zydus Wellness Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Zydus Wellness&#8217; live share price and get daily stock updates.<\/em><\/p>\n<p>The Zydus Wellness share price was trading around Rs 534 as results season played out in late August 2026, roughly 12.7% below its 52-week high of Rs 612 and well above its 52-week low of Rs 368. Promoter holding stood at 69.6% as of the June 2026 quarter.<\/p>\n<p>The Zydus Wellness share price has likely already absorbed some of this quarter&#8217;s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off. On profitability ratios, the company reports a return on equity of 3.98% and a book value of around Rs 183 per share, both useful reference points when judging whether the current price is reasonable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Risk\"><\/span><strong>Valuation Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 91.0x earnings against an industry average of 35.7x, the stock leaves little room for disappointment if growth slows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_Risk\"><\/span><strong>Profitability Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The quarter&#8217;s profit trend is the clearest risk here. Until Zydus Wellness shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Leverage_Risk\"><\/span><strong>Leverage Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A debt-to-equity ratio of 0.55 means the company&#8217;s earnings are more sensitive to interest rate and refinancing conditions than a lower-debt peer.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Demand_Risk\"><\/span><strong>Sector and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a health and wellness FMCG business, Zydus Wellness&#8217; results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Zydus Wellness share price well before the next result.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus Wellness&#8217; Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 7% to Rs 119 crore even as revenue rose. The Zydus Wellness share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter&#8217;s numbers until the margin trend turns around.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Zydus_Wellness_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Zydus Wellness Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Zydus_Wellness_Q1_FY27_results\"><\/span><strong>What were Zydus Wellness&#8217; Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Wellness reported Q1 FY27 revenue of Rs 1,441 crore, up 66.8% year on year, and PAT of Rs 119 crore, down 7.0% year on year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Zydus_Wellness_a_good_buy_after_its_Q1_FY27_results\"><\/span><strong>Is Zydus Wellness a good buy after its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Wellness&#8217; profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Zydus_Wellness_share_price_today\"><\/span><strong>What is the Zydus Wellness share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Zydus Wellness share price was trading around Rs 534 in late August 2026, about 12.7% below its 52-week high of Rs 612 and well above its 52-week low of Rs 368.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Zydus_Wellness_revenue_and_profit_for_Q1_FY27\"><\/span><strong>What is Zydus Wellness&#8217; revenue and profit for Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Wellness reported revenue of Rs 1,441 crore and a net profit of Rs 119 crore for the quarter ended June 30, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Zydus_Wellness_declare_a_dividend_with_its_Q1_FY27_results\"><\/span><strong>Did Zydus Wellness declare a dividend with its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No interim dividend was declared alongside Zydus Wellness&#8217; Q1 FY27 results. Investors should track the company&#8217;s next annual results for any dividend announcement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Zydus_Wellness_PE_ratio_and_is_it_expensive\"><\/span><strong>What is Zydus Wellness&#8217; PE ratio and is it expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Zydus Wellness share price trades at a trailing PE of 91.0x, against an industry average of 35.7x. Investors should compare this with the company&#8217;s growth rate before judging value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Zydus_Wellness_investors_right_now\"><\/span><strong>What are the key risks for Zydus Wellness investors right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At 91.0x earnings against an industry average of 35.7x, the stock leaves little room for disappointment if growth slows. As a health and wellness FMCG business, Zydus Wellness&#8217; results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Zydus Wellness share price well before the next result.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Zydus_Wellness_promoter_shareholding\"><\/span><strong>What is Zydus Wellness&#8217; promoter shareholding?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Promoter holding in Zydus Wellness stood at 69.6% as of the June 2026 quarter.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Zydus Wellness Q1 FY27: revenue Rs 1,441 crore, PAT Rs 119 crore. Full results breakdown and whether the stock is a buy at current levels.<\/p>\n","protected":false},"author":36,"featured_media":231797,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-231798","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["231797"],"_edit_lock":["1788523081:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["70"],"rank_math_title":["Zydus Wellness Share Price: Good Buy After Q1 FY27 Results?"],"rank_math_description":["Zydus Wellness share price in focus after Q1 FY27 results: PAT down 7% to Rs 119 crore, revenue at Rs 1,441 crore. Full results breakdown and valuation check inside."],"rank_math_focus_keyword":["Zydus Wellness share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["41805"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/is-zydus-wellness-a-good-buy-after-q1-fy27-results.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/231798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=231798"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/231798\/revisions"}],"predecessor-version":[{"id":232335,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/231798\/revisions\/232335"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/231797"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=231798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=231798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=231798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}